Blood Collection Market
Report ID: SQMIG35B2266
Report ID: SQMIG35B2266
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35B2266 |
Region:
Global |
Published Date: January, 2026
Pages:
183
|Tables:
112
|Figures:
72
Global Blood Collection Market size was valued at USD 11.01 Billion in 2024 and is poised to grow from USD 11.77 Billion in 2025 to USD 20.07 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026–2033).
The global blood collection market growth is emerging mainly for the reason that many patients suffering from chronic and infectious diseases such as diabetes, cancer, heart diseases, tuberculosis, and HIV increase the size of the market. There are many factors such as advanced technologies, increasing surgical procedures, and the elderly population which have made their respective contributions for which the market has grown steadily.
Furthermore, a significant contributory factor to speedy market growth is the increasing incidence of chronic diseases. For example, the International Diabetes Federation report released in 2024 also stated that 589 million people have diabetes currently. Future predictions indicate this huge number will grow to 853 million by 2050. In this respect, the increasing scope of residents suffering from chronic diseases creates a demand requiring precise and early identification of diseases related to blood collection, which contributes much to this process. Results from blood samples give a holistic picture of diagnostic information to act quickly with the best plans and personalized treatments. Thus, this growing need for diagnostic tools is likely to give a tremendous boom to growth in the blood collection industry.
How are Healthcare Providers Adopting Smart Blood Collection Tools?
The advancement of microfluidic point-of-care tools for blood tests, witnessed by CytoTracker from Rutgers University, is already an important milestone in blood collection. This tiny device, much like a glucometer test for blood sugar levels, uses microfluidic impedance cytometry to rapidly count white blood cells in one drop of blood. CytoTracker underwent clinical trials in 2024, which demonstrated quick and accurate reporting of results in minutes. Such advancements are changing the landscape of diagnostics by allowing for rapid on-site testing while minimizing the need for centralized labs, thus hastening medical intervention. These devices are of great benefit in areas without access to sophisticated medical facilities.
Market snapshot - 2026-2033
Global Market Size
USD 9.61 Billion
Largest Segment
Manual
Fastest Growth
Automated
Growth Rate
6.1% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global Blood Collection Market is segmented by Collection Site, Application, Method, End Use and region. Based on Collection Site, the market is segmented into Venous and Capillary. Based on Application, the market is segmented into Diagnostics and Treatment. Based on Method, the market is segmented into Manual and Automated. Based on End Use, the market is segmented into Hospitals, Diagnostics Centers, Blood Banks and Emergency Departments. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
As per the 2024 blood collection market analysis, the venous segment dominated the market, contributing to 82.68 percent of total sales. The demand for venous blood collection is much higher due to the increasing requirements for comprehensive diagnostic testing in various settings of health care. Rise in chronic diseases like diabetes, heart failure, and cancer also spikes the requirement for routine and advanced blood tests, many of which call for venous samples for accuracy. Increased sample volume from venous collection means that tests can be performed without multiple sample collections which are critical for patients with complex health needs. The increased number of decentralized clinical trials and home health services has further enhanced the need for venous collection as it allows broad and reliable testing necessary for tracking the health outcomes of patients at a distance.
The capillary segment is anticipated to have the highest blood collection market share during the forecast period because it is easy to use, requires no surgery, and allows testing to take place in the home and doctors office. Capillary sampling, typically done by simple finger prick, needs far less specialized equipment and is best for situations where small sample volumes are enough, like glucose monitoring, cholesterol testing, quick diagnostic tests. Telehealth is on the rise, and more people want health care services at home. Capillary collection allows patients to do tests at home, thus reducing the number of in-person visits and enabling regular remote monitoring.
As per the 2024 blood collection market forecast, the manual segment emerged as leader with a massive market share of 75.82%. It majorly gained application in a wide array of healthcare areas, such as in general care and specialty clinics where safe and cost-effective methods of blood collection were highly required. Manual collection that included either using syringes or vacuum-based tubes offered healthcare personnel more control and flexibility when compared to automated methods. This becomes very important when dealing with patients whose veins are difficult to find, such as children, the old, or those with certain medical issues. It is still applied in many areas, especially where there are difficulties in accessing sophisticated automated systems.
During the forecast period, the automated category is expected to increase at the fastest growth rate. Newer technologies make the procedure more accurate, safe, and efficient. Automated methods are extremely useful in different healthcare facilities such as hospitals, diagnostic labs, and donation centers where thousands of samples are processed daily. These methods absorb blood with almost no help from humans with the aid of very sophisticated instruments. Thus, these solutions improve patient convenience, streamline operations, and significantly decrease the potential for human errors making them a very viable option for medical establishments that aim to maintain a high standard of services while efficiently streamlining operations. Automated systems are also becoming popular in advanced regions that have healthcare infrastructures in place that could afford these expensive solutions to technology.
To get detailed segments analysis, Request a Free Sample Report
As per the blood collection market regional analysis, in 2024, North America continued to dominate blood collection sales, accounting for 40.93% of total revenue. There are several reasons why the North American market is growing, including increasingly more accidents, higher incidence of chronic and lifestyle diseases, and of an aging society. The increase in so-called noncommunicable diseases (NCDs), now the leading cause of death in the U.S., affecting 200 million and accounting for around 3.9 million deaths annually, can partly be attributed to people's increasingly sedentary lifestyles. Such new collection technologies, like home sampling kits and advanced diagnostic devices, conform to the ongoing requirement for disease management as well as preventive care. Further opportunities in the market are embraced in these new market openings that propel growth.
The blood collection market in the U.S. is predicted to grow considerably in coming years. This rise will result from an increase in the incidents of both chronic and infectious diseases, rapid improvement in blood collection technologies, and the heightened requirement for both routine and specialized testing. Some of the notable factors include increased incidences of preterm births, syphilis, and HIV, coupled with increased awareness and government initiatives such as CDC programs aimed at the elimination of HIV.
By 2024, the blood collection industry in Canada planned to make diagnostics more precise and useful. Nucleic acid amplification testing was the option most frequently embraced, while next-generation sequencing technology proved fastest to catch on. Increasingly, hospitals and specialty clinics bring advanced collection tools into play to improve health outcomes. Indeed, as dimensions of demand grow in ensuring safe, patient-oriented blood collection solutions, the industry also pays heavy attention to safety and regulation. This includes efforts to improve point-of-care testing and reduce bottlenecks within laboratory operations.
Europe formed a significant part of the blood collection market. Increase in the prevalence of chronic and infectious diseases such as diabetes, CVD, cancer, and asthma is the main factor driving the need for better and reliable methods of collection. This growth is also attributed to increased investments in healthcare infrastructure and research, more initiatives from market players, and the introduction of new diagnostic technologies.
Most of the growth in the UK blood collection market results from the increasing demand for improved diagnostic and monitoring tools. The important players that take part in the market are those companies that have strong footholds in the blood collection technologies sector. The diagnostics part of the market is rapidly increasing due to the rising number of chronic diseases occurring.
The blood collection market in France is anticipated to grow in the coming years because of a solid healthcare system, developed insurance policies, government support, and increased sick populations with infectious diseases. Seasonal outbreaks cause between 2 and 6 million cases each year and lead to 10,000 to 15,000 deaths, mostly in high-risk groups.
There are many factors that indicate the blood collection market in Germany will be expanding considerably. Primarily, it is very easy to get the advanced treatments and infrastructure in Germany due to a strong healthcare system that demands health insurance for 90% of the population, which, in turn, thrives upon developing the market.
The Asia-Pacific blood collection market is expected to review fast-growing figures on revenues during the forecast period. Rising healthcare demands, rapid advancements in technology, and an increasing population of elderly people will give more urgency to the demand for both effective blood collection technologies and better diagnostic tests. In India and Japan, there is now a rise in chronic diseases, especially cancer and diseases of the heart, which will lead in turn to further demand for better collection technologies and diagnostic tests. Japan has a fast-aging population and increasing cancer incidence, which in turn increases demand on the market. While this is the case, new initiatives and developments such as whole blood product innovations and utilization of DBS cards imply that efforts are underway to improve the healthcare infrastructure in this region. New collection devices and automated systems are but a few examples of how technology is effectively moving on fast towards better efficiency and comfort for the patients.
As in 2024, venous techniques will remain the most common means of blood collection in China; capillary collection will become more widely used in home test kits and outpatient clinics. As more urban hospitals are configuring their blood collection systems to be automated and semi-automated, it is still manual collection of methods that dominate in rural areas. The priorities of making all healthcare settings safe and minimizing errors in samples so certain diagnostics could potentially be made accessible to everyone have yet to be achieved.
Accuracy, safety, and comfort are what blood collection means in Japan. Though capillary techniques are increasingly adopted in home and outpatient setting tests, venous blood sampling is still the standard test procedure in hospitals and specialty clinics. Such advanced technologies as automation and barcoding for sample traceability are employed to avoid mistakes and assure smooth procedure workflow. Reliable methods were prioritized by health care practitioners for both children and elderly patients. It just goes to show how important in the US patient-centered, high-quality care becomes in presenting to patients.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Chronic Diseases on the Rise
Improvements on Collection Tools
Regulatory Issues for Clinical Validations
Costliness of Advanced Technology
Request Free Customization of this report to help us to meet your business objectives.
Major players are well known in the global blood collection market, commanding advancing product lines. Becton, Dickinson & Company (BD) heads the bill in this field. Their blood collection tubes and needles are well known to be of good quality and used in many healthcare facilities. Thermo Fisher Scientific stocks a huge catalog of blood collection tools and supplies to use in both diagnosis and treatment. They also made a name for themselves by producing specialized blood donations and collection devices, particularly in areas where high-precision technology is required: Fresenius Kabi and Terumo Corporation. These companies remain dominant in the market by having extensive ranges of innovative products, well-established distribution networks, and commitment towards changing healthcare standards.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, blood collection service will keep growing given the rising proportion of chronic illnesses, evolving technologies, and increasing inclination toward patient-centric care. Automation, robotic-assisted collection, and home sampling are all set to empower the changes required to make the procedures easier, safer, and more efficient. Nevertheless, high costs and stringent regulations remain key hurdles that need to be addressed. Both international corporates and budding entrepreneurs are making huge investments in the development of modern devices, point-of-care systems, and minimally invasive technologies. The gradual population growth may be attributed to initiatives for preventive care implementation, rising awareness of health issues, and increasing adoption of digital health solutions, which creates ample opportunities for both old and new enterprises to develop further innovations catering to evolving clinical and consumer needs in the global market.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 11.01 Billion |
| Market size value in 2033 | USD 20.07 Billion |
| Growth Rate | 6.9% |
| Base year | 2024 |
| Forecast period | 2026-2033 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Blood Collection Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Blood Collection Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Blood Collection Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Blood Collection Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
